Everfront Biotech Holding Company Limited (EFB)

Everfront Biotech Holding Company will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

EFB Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Year Ending	TTM	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-2.13	-2.29	-1.49
Depreciation & Amortization	0.04	0.04	0.04
Other Operating Activities	0.22	-0.03	-0.47
Operating Cash Flow	-1.87	-2.28	-1.92
Operating Cash Flow Growth	-	-	-

Year Ending	TTM	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Capital Expenditures	-0	-0.03	-
Change in Investments	-	-	-0
Other Investing Activities	-0.01	-0.01	-0
Investing Cash Flow	-0.01	-0.04	-0

Year Ending	TTM	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Debt Issued / Paid	-	2.51	0.3
Other Financing Activities	2.12	0.5	2.16
Financing Cash Flow	2.12	3.01	2.46

Year Ending	TTM	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Cash Flow	0.22	0.67	0.52

Year Ending	TTM	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Free Cash Flow	-1.87	-2.31	-1.92
Free Cash Flow Growth	-	-	-
Free Cash Flow Margin	-	-	-2407.77%